HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Johnson & Johnson Medical Inc.

Division of Johnson & Johnson
www.jnj.com

Latest From Johnson & Johnson Medical Inc.

Asia Executives On The Move: BMS Names New China GM, New President For Nippon Kayaku

The coming of summer has seen a flurry of executive changes in the Asia Pacific biopharma sector. BMS has named a new China GM amid a fierce immuno-oncology battle, Parexel Japan has a new president, and other personnel changes take place at Nippon Kayaku, Zai Lab and Harbour BioMed.

Appointments China

SAGES 2019: Spotlighting Competitive Robotic Systems And Procedures

Surgical robotics giant Intuitive Surgical will soon face competition from Medtronic and Verb Surgical. With the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) annual meeting on the way in Baltimore, MD this week, Wells Fargo analyst Larry Biegelsen offers an outlook on competitive robotic systems and the rising popularity by surgeons to use robotics systems in hernia, bariatric, cholecystectomy and colorectal procedures.

Artificial Intelligence Commercial

Pelvic Mesh Cases Continue As Endo Moves To Settle

Endo International announced plans this week to pay $775m to settle 22,000 US claims. Meanwhile, J&J is launching its sixth mesh lawsuit in Philadelphia and questioning jurisdiction.

Legal Issues Medical Device

Medtronic Looking To Buy Smith & Nephew? Analysts Doubt It

Medtronic may be looking to buy the British orthopedics device company in part so that it can move its home to the UK for tax purposes, according to a report from Bloomberg. But Securities analysts report that the rumored deal probably does not make sense for Medtronic.

Medical Device Business Strategies
See All
UsernamePublicRestriction

Register